Stroke
Showing of 12 results
University Hospitals Nationally Recognized for High-Quality Stroke Care
The American Heart Association presents Get With The Guidelines® - Stroke awards for proven dedication to ensuring all stroke patients have access to best practices and life-saving care.
Two UH Physician-Scientists to Receive 2024 Top Ten Clinical Research Achievement Awards
Mehdi Shishehbor, DO, MPH, PhD, and Amrou Sarraj, MD, will receive honors from the Clinical Research Forum in a ceremony to be held April 2 in Las Vegas.
International Study Finds Thrombectomy Highly Effective Long-Term Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.
University Hospitals Nationally Recognized for Commitment to High-Quality Stroke Care
American Heart Association presents multiple hospitals within the UH system Get With The Guidelines® awards for proven dedication to best practices and life-saving care
New Major International Study Finds Thrombectomy Highly Effective Treatment for Large Strokes
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in New England Journal of Medicine presented at International Stroke Conference
UH Nationally Recognized for Efforts to Reduce Uncontrolled Blood Pressure to Battle Diabetes, Heart Disease and Stroke
Awards from the American Heart Association, American Medical Association, and American Diabetes Association laud University Hospitals' focus on some of the most common and devastating conditions plaguing the health of Americans today.
Several UH Hospitals Recognized by American Heart Association for Quality Stroke Care
The American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Quality Achievement Awards, achieved by UH medical centers, commitment to ensuring stroke patients receive the best and most appropriate treatment.
UH Implements Plan to Shift to Tenecteplase Over Alteplase (tPA) for Acute Ischemic Stroke
University Hospitals among the first health systems in the U.S. to use faster acting, genetically engineered version of the clot-busting tPA drug.